Bicoastal venture firm New Enterprise Associates owns 75.2 percent of GlycoMimetics Inc., making NEA by far the biggest beneficiary of…
Super UserOctober 8, 2013
Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD), has successfully developed a neutropenic mouse thigh model…
Super UserOctober 7, 2013
Donald E. Ingber, a professor at Harvard University, has combined advanced electronics and biology to create a "lung on a…
Super UserOctober 7, 2013
GlycoMimetics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange…
Super UserOctober 7, 2013
Even people without diabetes could be at higher risk of dying from disease High blood sugar has been linked to…
Super UserOctober 7, 2013
BioMarker Strategies announced the appointment of Jerry Parrott as President, Chief Executive Officer and Director, effective immediately. According to a…
Super UserOctober 7, 2013
Fyodor, a Baltimore-based biotechnology company, announced today that the US National Science Foundation (NSF) has awarded the company a Small…
Super UserOctober 7, 2013
Berlin, Germany, and U.S.A. - Epigenomics AG (Frankfurt Prime Standard: ECX, OTC: EPGNY), the German-American cancer molecular diagnostics company, announced…
Super UserOctober 7, 2013
Chevy Chase-based New Enterprise Associates has joined in a $10 million financing for Cydan LLC, a Cambridge, Mass.-based orphan drug…
Super UserOctober 7, 2013